Indonesia
14 Vaccines Approved for Use in Indonesia
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
Approval Source: reuters.com
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
21 trials in 5 countries
Approval Source: reuters.com
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated
Shenzhen Kangtai Biological Products Co
KCONVAC
Approved in 2 countries
7 trials in 1 country
Approval Source: barrons.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Inactivated
Protein Subunit
PT Bio Farma
IndoVac
Approved in 1 country
4 trials in 1 country
Approval Source: texaschildrens.org
RNA
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
19 in Clinical Trials in Indonesia
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
21 trials in 5 countries
Protein Subunit
West China Hospital
Recombinant (Sf9 cell)
9 trials in 5 countries
RNA
Walvax
mRNA
4 trials in 3 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Protein Subunit
Adimmune Corporation
AdimrSC-2f
3 trials in 2 countries
Protein Subunit
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine
5 trials in 1 country
Replicating Viral Vector
Aivita Biomedical Inc
AV-COVID-19
4 trials in 2 countries
Inactivated
Airlangga University
UNAIR Inactivated COVID-19 Vaccine
3 trials in 1 country
Protein Subunit
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Protein Subunit
PT Bio Farma
IndoVac
Approved in 1 country
4 trials in 1 country
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
RNA
Walvax
AWcorna
Approved in 1 country
4 trials in 3 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
RNA
Suzhou Abogen Biosciences
ABO-CoV.617.2
RNA
Suzhou Abogen Biosciences
ABO1009-DP
2 trials in 2 countries